Phase 2 study of definitive chemoradiotherapy for locally advanced esophageal cancer being responsive to induction chemotherapy
Phase 2
Recruiting
- Conditions
- esophageal cancer
- Registration Number
- JPRN-UMIN000005295
- Lead Sponsor
- Department of Gastroenterological Surgery,Graduate School of medicine,Osaka University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Not provided
Exclusion Criteria
patients with serous concomitant diseas patients with serious infectiou disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Complete response rate
- Secondary Outcome Measures
Name Time Method Adverse effact,Ovarall survival,Relapse free survival, Survaival free from esophageal resction response rate
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie chemoradiotherapy response in locally advanced esophageal cancer after induction chemotherapy?
How does definitive chemoradiotherapy compare to surgery-based approaches in locally advanced esophageal cancer treatment?
Which biomarkers predict favorable outcomes for chemoradiotherapy in esophageal cancer patients post-induction chemotherapy?
What are the common adverse events associated with definitive chemoradiotherapy for locally advanced esophageal cancer and their management strategies?
Are there combination therapies or targeted agents that enhance definitive chemoradiotherapy efficacy in esophageal cancer?